The Unique Challenges of the Fentanyl Epidemic
The U.S. Centers for Disease Control and Prevention (CDC) estimates that 107,477 drug-related deaths occurred from August 2021 to August 2022, with the majority attributed to the potent synthetic opioid, fentanyl. These provisional estimates reflect a modest (2.57%) decrease from the previous year, defying an increasing trend that has persisted for the last 20 years where opioids have been the primary driver of overdose deaths. Through its evolutions, the current opioid epidemic has proven to be an ever-moving target, and there’s much we still need to learn in order to curb fentanyl exposure and overdose.
The origins...
Source: TIME: Health - April 6, 2023 Category: Consumer Health News Authors: Jermaine Jones Tags: Uncategorized freelance health Source Type: news
Nanoparticle with mRNA appears to prevent, treat peanut allergies in mice
Key takeawaysPeanuts are one of the most common food allergens for children.UCLA scientists have developed a nanoparticle that delivers mRNA to liver cells in order to teach the immune system to tolerate peanut protein and alleviate allergies.In mice, the nanoparticle successfully dampened symptoms of serious allergy.Peanut allergies affect 1 in 50 children, and the most severe cases lead to a potentially deadly immune reaction called anaphylactic shock.Currently, there is only one approved treatment that reduces the severity of the allergic reaction, and it takes months to kick in. A group of UCLA immunologists is aiming ...
Source: UCLA Newsroom: Health Sciences - April 3, 2023 Category: Universities & Medical Training Source Type: news
Nasal COVID-19 vaccine heads for human testing
Researchers in Germany said a trial of COVID-19 vaccination administered through the nose has shown great promise in animal testing and is now preparing for Phase I clinical trials in humans. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 3, 2023 Category: Consumer Health News Source Type: news
ERLEADA ® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.
HORSHAM, Pa., April 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA® (apalutamide) in the United States. The introduction of the 240mg tablet provides the first-and-only option for a once-daily, single-tablet Androgen Receptor Inhibitor (ARI) approved for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).With two strengths available, healthcare professionals will have the flexibility to...
Source: Johnson and Johnson - April 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
News at a glance: A particle ’s weighty measurement, Marburg in Africa, and a fossil called “the blob”
PARTICLE PHYSICS
Particle mass dispels hint of new physics
A fleeting, weighty elementary particle called the W boson has just the mass predicted by theory, physicists working with Europe’s Large Hadron Collider (LHC) reported this week at a conference in Italy. The finding comes from ATLAS, one of four large particle detectors fed by the LHC, and it contradicts
the eyebrow-raising measurement
reported last year in
Science
that suggested
the W was heavier than predicted by physicists’ prevailing standard model
. That discrepancy could have signaled that massive ne...
Source: ScienceNOW - March 30, 2023 Category: Science Source Type: news
New RYBREVANT ® (amivantamab-vmjw) Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
COPENHAGEN, DENMARK, March 29, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new long-term data from the CHRYSALIS study evaluating RYBREVANT® (amivantamab-vmjw) in patients with advanced non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease progressed on prior platinum-based chemotherapy.1 Data from the study showed long-term response and safety in this population and were presented in an oral presentation at the 2023 European Lung Cancer Congress (ELCC) (Abstract #779).1In the analysis of the CHRYSALIS study, inve...
Source: Johnson and Johnson - March 29, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Animal vaccine startup sets up research hub in RTP
An Iowa-based startup developing vaccines that can be delivered to animals orally has set up a research and development hub in the Triangle. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 24, 2023 Category: American Health Authors: Zac Ezzone Source Type: news
Tanzania: Rinderpest Vaccine in Pipeline
[Daily News] THE Tanzania Veterinary Laboratory Agency (TVLA) is in the final stage of making a rinderpest vaccine to protect livestock from the disease and help livestock keepers increase their income. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2023 Category: African Health Source Type: news
Two New Vaccines Against Bird Flu Effective in Dutch Lab: Govt Two New Vaccines Against Bird Flu Effective in Dutch Lab: Govt
Two vaccines tested by a Dutch veterinary research center have proved effective against highly infectious bird flu in a first experiment conducted under a controlled environment, the Dutch government said on Friday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2023 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Third Scientific Conference and sixth EMARIS meeting on acute respiratory infections in the ...
18 March 2023 – Focusing on better preparedness, early detection, rapid response, and enhanced research for respiratory diseases, the Third Scientific Conference and the sixth EMARIS meeting on acute respiratory infections in the Eastern Mediterranean Region concluded in Muscat, Oman.
Serving as a platform to showcase partnership and solidarity, the 3-day meeting and conference convened more than 200 health experts from WHO, Member States, US Centers for Disease Control and Prevention and partner organizations.
Besides extensive deliberations, the recommendations of the meeting and conference focused o...
Source: WHO EMRO News - March 19, 2023 Category: Middle East Health Source Type: news
Next Ebola Outbreak ‘Not a Matter of If, but When’
Uganda used public health measures like screening, testing of temperatures, and isolation of suspected cases to contain the Ebola outbreak. While those measures were successful, scientists warn that another outbreak could occur. Credit: Wambi Michael/IPSBy Wambi MichaelKAMPALA & MUBENDE, Mar 10 2023 (IPS) It is two months since the World Health Organization declared Uganda free of the most recent Sudan ebolavirus, which killed 55 people.
Uganda employed public health measures to end the outbreak. In the absence of vaccines and therapeutics, the threat of the next outbreak looms.
Scientists are yet to find answers to quest...
Source: IPS Inter Press Service - Health - March 10, 2023 Category: International Medicine & Public Health Authors: Wambi Michael Tags: Africa Editors' Choice Environment Featured Headlines Health TerraViva United Nations IPS UN Bureau IPS UN Bureau Report Uganda Source Type: news
Forget ChatGPT: The Greatest Tech Breakthrough Would Be Getting Cell Phones to Rural Women
A cell phone gives rural women access to financial services, training, networks, and, importantly, information and knowledge. Credit: Prashanth Vishwanathan (CCAFS)By Nicoline de HaanNAIROBI, Kenya, Mar 6 2023 (IPS) While 100 million people worldwide are using the AI chatbot ChatGPT to get ahead on homework and try out for top jobs at Google, more than 370 million women in developing countries lack the services of a simple cell phone.
The world may be witnessing a quantum leap in the digital revolution, but cell phones and mobile internet would give these women enough of a foothold to access unprecedented opportunities to...
Source: IPS Inter Press Service - Health - March 6, 2023 Category: International Medicine & Public Health Authors: Nicoline de Haan Tags: Africa Climate Change Development & Aid Education Food and Agriculture Food Security and Nutrition Gender Global Headlines Health Inequality Innovation TerraViva United Nations IPS UN Bureau Source Type: news
No, You Shouldn ’t Be Afraid of Fungi
By now, you’ve probably heard about “zombie fungi”, which are able to puppet the behaviour of their insect hosts with magnificent precision. One such fungus, Ophiocordyceps unilateralis, infects carpenter ants. Once infected by the fungus, ants are stripped of their instinctive fear of heights and climb up the nearest plant. In due course the fungus forces the ant to clamp its jaws around the plant in a “death grip.” The fungus then digests the ant’s body and projects a stalk-like structure out of its head, from which spores shower down on ants passing below.
Unlike the fictional killer ...
Source: TIME: Science - February 19, 2023 Category: Science Authors: Giuliana Furci and Merlin Sheldrake Tags: Uncategorized climate change Evergreen freelance Source Type: news
Africa: I Bonded With Covid Vaccine Sceptics Over Saunas and Mother Earth Rituals - This Is What They Taught Me
[The Conversation Africa] I was standing in a forest at night, by a dark lake taking part in a Mother Earth ritual. Shaman drums echoed between the cliffs. The witch leading the ritual suddenly encouraged us to sound like wild animals. The other women seemed to greet this as something predictable and expected. "Stand up, let your inner spirit out, the wild animal within you!" the witch called out. And then she laughed out loud into the darkness - and just howled. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 19, 2023 Category: African Health Source Type: news
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
